News two regions, as of June 2012, while the ministry of health treats about 400. One of the
barriers to getting people on treatment is the stigma associated with TB.“It's more than HIV,” …

The first question is do we need any new anti-TB drugs since the majority of people who
currently die with TB actually have fully sensitive disease which has led some to advocate …

862 Editorial (multidrug-resistant tuberculosis), when the WHODOTS program is followed.
The early detection of tuberculosis and particularly MDR-TB is addressed here (Victor et al.) …

Background: For decades there were no significant advances in the development of
diagnostic procedures for drug resistant TB (DR-TB), or the availability of new, effective …

TB patients progress from exposure to cure in discrete steps: infection, symptoms, clinic visit,
diagnosis, treatment onset, conversion from an active infection to a noncontagious state, and …

Rationale: Worldwide, TB (Tuberculosis) is one of the top 10 causes of death and the
leading cause from a single infectious agent above HIV/AIDS (Acquired Immunodeficiency …

10© JAPI• August 2012• VOL. 60 and up-gradation of physicians cannot be left to the
individual physician. Out of the 96 million USD first-line anti-TB drug market in India in 2006 …

A case is reported of a 21-year old female referred to a public hospital in Johannesburg,
South Africa, for management of psychosis. She was previously documented to have Human …

Multidrug-resistant and extremely drug-resistant tuberculosis strains threaten to become an
intractable problem. Misuse of antibiotics and inadequacy of diagnostic tools have fostered …